Last reviewed · How we verify
local intracoronary dosis of Paclitaxel
local intracoronary dosis of Paclitaxel is a Taxane Small molecule drug developed by University Hospital Tuebingen. It is currently in Phase 3 development for Coronary in-stent restenosis.
Paclitaxel works by inhibiting cell division, thereby preventing cancer cells from multiplying.
Paclitaxel works by inhibiting cell division, thereby preventing cancer cells from multiplying. Used for Coronary in-stent restenosis.
At a glance
| Generic name | local intracoronary dosis of Paclitaxel |
|---|---|
| Sponsor | University Hospital Tuebingen |
| Drug class | Taxane |
| Target | Microtubules |
| Modality | Small molecule |
| Therapeutic area | Oncology |
| Phase | Phase 3 |
Mechanism of action
Paclitaxel binds to tubulin, a protein that makes up microtubules, and prevents them from disassembling. This leads to the accumulation of stable microtubules, which in turn prevents the cell from entering the mitotic phase of cell division. As a result, cancer cells are unable to multiply and eventually die.
Approved indications
- Coronary in-stent restenosis
Common side effects
- Myelosuppression
- Neutropenia
- Anemia
- Thrombocytopenia
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- local intracoronary dosis of Paclitaxel CI brief — competitive landscape report
- local intracoronary dosis of Paclitaxel updates RSS · CI watch RSS
- University Hospital Tuebingen portfolio CI
Frequently asked questions about local intracoronary dosis of Paclitaxel
What is local intracoronary dosis of Paclitaxel?
How does local intracoronary dosis of Paclitaxel work?
What is local intracoronary dosis of Paclitaxel used for?
Who makes local intracoronary dosis of Paclitaxel?
What drug class is local intracoronary dosis of Paclitaxel in?
What development phase is local intracoronary dosis of Paclitaxel in?
What are the side effects of local intracoronary dosis of Paclitaxel?
What does local intracoronary dosis of Paclitaxel target?
Related
- Drug class: All Taxane drugs
- Target: All drugs targeting Microtubules
- Manufacturer: University Hospital Tuebingen — full pipeline
- Therapeutic area: All drugs in Oncology
- Indication: Drugs for Coronary in-stent restenosis
- Compare: local intracoronary dosis of Paclitaxel vs similar drugs
- Pricing: local intracoronary dosis of Paclitaxel cost, discount & access